Kaposi Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Kaposi Sarcoma Clinical Trials Market Report Overview
The Kaposi Sarcoma Clinical Trial provides an overview of Kaposi Sarcoma Clinical trials scenario. The report provides top line data relating to the clinical trials on Kaposi Sarcoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Kaposi Sarcoma Clinical Trials Market Segmentation by Regions and Countries
The key regions in the kaposi sarcoma clinical trials market are Europe, the Asia-Pacific, North America, the Middle East & Africa, and South & Central America. North America dominated the market with more than 50% of the clinical trials conducted as of February 2023.
In the country wise analysis, as of February 2023, the US has the highest number of kaposi sarcoma clinical trials, followed by China, France, the UK, Italy, Russia, Uganda, Canada, Australia, and Belgium.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United States have the highest proportion of Kaposi Sarcoma to Infectious Disease clinical trials as of February 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of kaposi sarcoma to infectious clinical trials as of February 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Kaposi Sarcoma Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the kaposi sarcoma clinical trials market, download a free report sample
Kaposi Sarcoma Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the kaposi sarcoma clinical trials market are institution, company, and the government. Out of them, more than 50% of trials have been sponsored by institution and around 45% by company.
Kaposi Sarcoma Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the kaposi sarcoma clinical trials market, download a free report sample
Kaposi Sarcoma Clinical Trials Market - Competitive Landscape
The leading sponsors in the kaposi sarcoma clinical trials market are Bristol-Myers Squibb Co, Emmes Co LLC, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Merck & Co Inc, PTC Therapeutics Inc, F. Hoffmann-La Roche Ltd, and Dr. Reddy’s Laboratories Ltd. Bristol-Myers Squibb Co has conducted the highest number of kaposi sarcoma clinical trials and is followed by Emmes Co LLC and Pfizer Inc.
Kaposi Sarcoma Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the kaposi sarcoma clinical trials market, download a free report sample
Kaposi Sarcoma Clinical Trials Market Report Overview
Key Regions | Europe, Asia-Pacific, North America, Middle East & Africa, and South & Central America |
Key Countries | The US, China, France, The UK, Italy, Russia, Uganda, Canada, Australia, and Belgium |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Bristol-Myers Squibb Co, Emmes Co LLC, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Merck & Co Inc, PTC Therapeutics Inc, F. Hoffmann-La Roche Ltd, and Dr. Reddy’s Laboratories Ltd |
Segments Covered in the Report
Kaposi Sarcoma Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Kaposi Sarcoma Clinical Trials Country Outlook (2023)
- The US
- China
- France
- The UK
- Italy
- Russia
- Uganda
- Canada
- Australia
- Belgium
Kaposi Sarcoma Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment.
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Emmes Co LLC
Pfizer Inc
Ligand Pharmaceuticals Inc
Sequus Pharmaceuticals Inc (Inactive)
AstraZeneca Plc
Merck & Co Inc
Dr. Reddy's Laboratories Ltd
F. Hoffmann-La Roche Ltd
PTC Therapeutics Inc
Table of Contents
Frequently asked questions
-
Which was the key region in the kaposi sarcoma clinical trials market?
North America dominated the kaposi sarcoma clinical trials market as of February 2023.
-
Which was the leading country in the G7 kaposi sarcoma clinical trials market?
The United States have the highest proportion of Kaposi Sarcoma to Infectious Disease clinical trials as of February 2023.
-
Which was the leading country in the E7 kaposi sarcoma clinical trials market?
Russia has the highest proportion of kaposi sarcoma to infectious clinical trials as of February 2023.
-
What are the key sponsor types in the kaposi sarcoma clinical trials market?
The key sponsor types in the kaposi sarcoma clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the kaposi sarcoma clinical trials market?
The leading sponsors in the kaposi sarcoma clinical trials market are Bristol-Myers Squibb Co, Emmes Co LLC, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Merck & Co Inc, PTC Therapeutics Inc, F. Hoffmann-La Roche Ltd, and Dr. Reddy’s Laboratories Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Kaposi Sarcoma reports

